Positions
- Associate Professor
-
Medicine-Gastroenterology
ÌÇÐÄvlogÃÛÌÒ of Medicine
Houston, TX, US
- Member
-
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄvlogÃÛÌÒ of Medicine
Houston, Texas, United States
Education
- PhD from University Of Texas School Of Public Health
- 04/2004 - Houston, TX, United States
- Molecular and genetic epidemiology of smoking-related pancreatic cancer
- MS from Chinese Academy Of Preventive Medicine
- 07/1997 - Beijing, China, People's Rep
- Interleukin 2 system in male smokers
- MD from Tongji Medical University
- 07/1994 - Wuhan, China, People's Rep
- Environmental Medicine
Professional Interests
- Epidemiology and outcomes of gastrointestinal cancers
- Molecular epidemiology
- Genetic epidemiology
- Dietary intake
- Obesity
- Biomarkers
- Insulin resistance
- Chronic inflammation
Professional Statement
Our research goals are to identify genetic and modifiable environmental risk factors for digestive cancers as well as to search for intermediate biomarkers of environment exposure and new targets for pharmaceutical or behavioral intervention. The current research is designed to understand the origin of chronic inflammation and disturbed immune homeostasis in population-based studies.
Websites
Publications
New study reveals drinking coffee regularly can lead to this super coveted health benefit
Selected Publications
-
Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM. " " Cancer Epidemiol. Biomarkers Prev.. 2005 Jun ; 14 (6) : 1470-6.
Pubmed PMID: . -
Jiao L, Mitrou PN, Reedy J, Graubard BI, Hollenbeck AR, Schatzkin A, Stolzenberg-Solomon R. " " Arch. Intern. Med.. 2009 Apr 27; 169 (8) : 764-70.
Pubmed PMID: . -
Bao Y, Stolzenberg-Solomon R, Jiao L, Silverman DT, Subar AF, Park Y, Leitzmann MF, Hollenbeck A, Schatzkin A, Michaud DS. " " Am. J. Clin. Nutr.. 2008 Aug ; 88 (2) : 431-40.
Pubmed PMID: . -
Jiao L, Taylor PR, Weinstein SJ, Graubard BI, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. " " Cancer Epidemiol. Biomarkers Prev.. 2011 Jul ; 20 (7) : 1430-8.
Pubmed PMID: .
Memberships
- American Association for Cancer Research
- Active member (01/2012)
Funding
-
Advanced glycation end products and colorectal cancer risk in women
#1R03CA156626-01 - (09/01/2011 - 08/31/2014)
- Grant funding from National Cancer Institute
- Pre-diagnostic circulating concentrations of CML-AGE and sRAGE and risk of colorectal cancer in a prospective case-cohort study.
-
Advanced Glycation End-Products and Risk of Pancreatic Cancer
#1R01CA172880-01A1 - (09/20/2013 - 07/31/2016)
- Grant funding from National Cancer Institute
-
Toll-like receptors and risk of colorectal adenoma
- $60,000.00 (05/12/2012 - 05/31/2014)
- Gift funding from Gillson-Longenbaugh Foundation
-
Toll-like receptors and colorectal cancer survival
- Gift funding from Golfers against cancer
-
Toll-like receptors, gut microbiota, and risk of colorectal adenoma
#RP140767 - (08/31/2014 - 08/30/2017)
- CPRIT (Cancer Prevention and Research Institute of Texas)
-
1. Targeted serum metabolites profiling in early detection of pancreatic cancer
- (01/01/2015 - 08/31/2015)
- Grant funding from NHLBI
- This study aims to identify metabolites specific to pancreatic cancer in a prospective study.
Skills
- molecular epidemiology study; genetics; statistics;
Languages
Chinese (Gan)
to edit your profile